Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Pulsed electric field treatment may help shrink untreated liver tumors.

Fat tissue extract may help treat vitiligo by reducing cell stress and promoting skin repair.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

ATX-101 injections can cause hair loss.

Certain pesticides may delay sexual maturity in teenage boys.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Talquetamab may cause hair loss and skin issues.

The new testosterone patch works as well as the gel.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

The research improved understanding of yak hair growth to help use yak wool better.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Blocking a specific receptor slows down hair loss in mice.

Deleting Rac1 in the skin depletes stem cells and damages hair follicles.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.